VASCUGEN

Cell culture media supplements for laboratory use, scientific and research use; chemical, biological and diagnostic reagents and prepared laboratory media for scientific or research purposes; biological preparation for use in vascular and cardiovascular cell culture media other than for medical or veterinary use; cell culture media supplement used for the production of biological therapeutics; stem cell culture reagent system comprising chemical culture nutrients, culture growth proteins and protein microarrays for the expansion of stem cells for research and manufacturing use; Biological preparations, namely, genetically modified cells for clinical and commercial use in scientific research, and for use in pharmaceutical research; Cell growth media and conditioned media for growing cells for scientific use, research use or commercial use other than for medical or veterinary purposes

Medicines for stimulation of vascular and cardiovascular regeneration; pharmaceuticals for stimulation of vascular and cardiovascular regeneration using stem cells and allogenic cells; chemical and diagnostic preparations for medical purposes for treatment of vascular and cardiovascular diseases; pharmaceutical preparations for the treatment and prevention of vascular and cardiovascular diseases; chemical, biological and diagnostic reagents and prepared laboratory media for clinical or medical purposes; pharmaceutical preparations for the treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia; Biological preparations, namely, genetically modified cells for medical and therapeutic purposes; Derivatives and modulators of cultured cells, namely, conditioned media for medical use; biologics, biotherapeutics, and therapeutics, namely, extracellular vesicle-based therapeutics for the prevention and treatment of vascular and cardiovascular diseases and disorders

Development of pharmaceutical preparations and medicines; medical and scientific research in the field of vascular and cardiovascular impairments; medical and scientific research in the field of allogeneic cell therapy; medical and scientific research in the field of regenerative medicine; providing medical and scientific research information in the field of regenerative medicine, vascular and cardiovascular impairments, and allogenic cell therapies; medical and scientific research in the field of treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia